The FDA has approved Varubi for use in combination with other antiemetic agents to prevent delayed chemotherapy-induced nausea and vomiting from initial and repeat chemotherapy regimens, including ...
CINV also creates substantial indirect costs. The effects on patient and caregiver productivity can be tremendous, as managing CINV and making unanticipated visits consumes much time. A survey ...
Chemotherapy-induced nausea and vomiting can be reduced with certain FDA-approved drugs. Newly diagnosed patients recommended for chemotherapy have less reason to worry about nausea and vomiting, as ...
Please provide your email address to receive an email when new articles are posted on . Pekle and colleagues conducted a retrospective analysis of a phase 3 study that determined the efficacy and ...
New draft guidance from the US Food and Drug Administration (FDA) updates which endpoint assessments and evidence are needed to show efficacy for medicines that treat chemotherapy-induced nausea and ...
Medical marijuana may hold some promise for treating chemotherapy-induced nausea and vomiting (CINV) and seizures in children and adolescents, a new systematic review and meta-analysis published in ...
The recent research report published by Market Expertz on the Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market renders the latest information and valuable insights to the readers to ...
Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) -- In 2021, the global CINV existing and pipeline drugs market was estimated to be worth US$ 1.9 billion. It is expected to increase ...
For patients with cancer, chemotherapy-induced nausea and vomiting (CINV) can strike a major blow to quality of life. Sometimes, it can become so severe that patients are reluctant to continue ...
Acupuncture for breast cancer CINV is being systematically compared. Read more about this upcoming evidence review.
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, ...